Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
But when you combine glucagon receptor agonism with strong GLP-1 and GIP activity, something interesting happens: GLP-1 and GIP's insulin-stimulating effects offset glucagon's glucose-raising tendency, and what's left is glucagon's other effects increased hepatic energy expenditure, upregulated fatty-acid oxidation, and thermogenesis
GLUTag cells were routinely cultured in Dulbeccos modified Eagles medium, 1 g/l glucose, supplemented with 10% FBS, and 2 mM glutamine
Trends in Endocrinology and Metabolism: TEM, 24 (2), 8591
Flint A, Raben A, Rehfeld JF, Holst JJ, Astrup A
J Biol Chem (1984) 259:14,0827
The glucagon-like peptide 1 (GLP-1) market has witnessed robust growth, expanding from $22.06 billion in 2025 to an expected $23.88 billion in 2026, at a compound annual growth rate (CAGR) of 8.2%
US$ 27.05
US$ 23.65
US$ 20.06
US$ 29.00
US$ 26.81
US$ 20.61
US$ 23.11
US$ 21.46
US$ 28.90
US$ 23.35
US$ 29.44
